Clinical trial
Preoperative Estetrol in Breast Cancer
NCT00464516 · Pantarhei Bioscience, Industry · Completed
Key facts
| NCT number | NCT00464516 |
|---|---|
| Title | Preoperative Estetrol in Breast Cancer |
| Official title | Preoperative Hormone Therapy for Pre- and Postmenopausal Women With ER Positive Breast Cancer: A Double Blind Randomized Parallel Group Phase II Trial, Comparing the Effect of 2 Weeks of Preoperative Estetrol With Placebo |
| Lead sponsor | Pantarhei Bioscience, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | placebo, Estetrol |
| Enrollment | 30 |
| Start date | Apr 1, 2007 |
| Primary completion | Feb 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Apr 23, 2007 |
| Last update posted | Jul 2, 2012 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: